The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 10, 2020

Filed:

Jul. 25, 2005
Applicants:

J. Marc Simard, Baltimore, MD (US);

Mingkui Chen, Omaha, NE (US);

Inventors:

J. Marc Simard, Baltimore, MD (US);

Mingkui Chen, Omaha, NE (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61P 9/10 (2006.01); A61K 38/43 (2006.01); A61K 31/165 (2006.01); A61K 31/565 (2006.01); A61K 31/566 (2006.01); A61K 31/00 (2006.01); A61K 38/48 (2006.01); A61K 31/40 (2006.01); A61K 38/17 (2006.01); A61K 31/175 (2006.01); A61K 31/549 (2006.01); A61K 31/64 (2006.01); A61K 31/44 (2006.01); A61K 45/06 (2006.01); A61K 38/49 (2006.01); C07K 14/47 (2006.01);
U.S. Cl.
CPC ...
A61K 31/00 (2013.01); A61K 31/165 (2013.01); A61K 31/175 (2013.01); A61K 31/40 (2013.01); A61K 31/44 (2013.01); A61K 31/549 (2013.01); A61K 31/565 (2013.01); A61K 31/566 (2013.01); A61K 31/64 (2013.01); A61K 38/177 (2013.01); A61K 38/482 (2013.01); A61K 38/49 (2013.01); A61K 45/06 (2013.01); A61P 9/10 (2018.01); C07K 14/4705 (2013.01);
Abstract

The present invention is directed to therapeutic compositions targeting the NCchannel of an astrocyte, neuron or capillary endothelial cell and methods of using same. More specifically, agonists and antagonists of the NCchannel are contemplated. The therapeutic compositions are used to treat cancer, more specifically, a metastatic brain tumor, wherein a tumor-brain barrier is present. Such treatments are contemplated in combination with conventional anti-cancer therapies. Alternatively, the compositions are used to prevent cell death and to treat cerebral edema that result from ischemia, due to interruption of blood flow, to tissue trauma or to increased tissue pressure.


Find Patent Forward Citations

Simard, J.. (2020). Therapeutic methods that target the ncchannel (U.S. Patent No. 10583094). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10583094

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…